Literature DB >> 31727547

Reperfusion therapies and poststroke seizures.

Carla Bentes1, Francesco Brigo2, Johan Zelano3, José M Ferro4.   

Abstract

Seizures are not only a frequent complication of stroke but have been associated with an unfavorable functional and vital outcome of patients who have had stroke. Facing a new paradigm of acute standard stroke care, acute symptomatic seizures in this clinical setting deserve to be rethought. Reperfusion therapies, the gold standard treatment for acute ischemic stroke, improve long-term survival and outcome of patients who have had stroke and have been associated both with clinical seizures and the occurrence of epileptiform activity in the electroencephalogram (EEG). This narrative review describes the different physiopathological mechanisms underlying the possible association between reperfusion therapies and seizures, both acute symptomatic seizures and unprovoked seizures, and the current evidence regarding the risk of poststroke seizures in treated patients. It also identifies the gaps in our knowledge to foster future studies in this field. By different mechanisms, reperfusions therapies may have opposing effects on the risk of poststroke seizures. There is a need for a better definition of the specific physiopathology of seizures in clinical practice, as many factors can be recognized. Additionally, most of the current clinical evidence refers to acute symptomatic seizures and not to unprovoked seizures or poststroke epilepsy, and our analysis does not support the existence of a strong association between thrombolysis and poststroke seizures. So far, the impact of reperfusion therapies on the frequency of poststroke seizures is unclear. To study this effect, many clinical challenges must be overcome, including a better and clear operational definition of seizures and stroke characteristics, the standard of stroke and epilepsy care and EEG monitoring, and the degree of reperfusion success. Prospective, high quality, larger, and longer follow-up multicentric studies are urgently needed. Additionally, stroke registries can also prove useful in better elucidate whether there is an association between reperfusion therapies and seizures. This article is part of the Special Issue "Seizures & Stroke".
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute symptomatic seizures; Epilepsy; Reperfusions therapies; Stroke; Thrombolysis; Unprovoked seizures; rtPA

Mesh:

Year:  2019        PMID: 31727547     DOI: 10.1016/j.yebeh.2019.106524

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Risk Factors for Postischemic Stroke Epilepsy in Young Adults: A Nationwide Population-Based Study in Taiwan.

Authors:  Phuong Thao Do; Li-Ying Chen; Lung Chan; Chaur-Jong Hu; Li-Nien Chien
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

Review 2.  Recent advances in the role of excitation-inhibition balance in motor recovery post-stroke.

Authors:  Ioana-Florentina Grigoras; Charlotte J Stagg
Journal:  Fac Rev       Date:  2021-06-23

3.  Go Ahead! Use that Reperfusion Treatment, don't Worry About Subsequent Seizures!

Authors:  Vineet Punia
Journal:  Epilepsy Curr       Date:  2022-01-28       Impact factor: 7.500

Review 4.  Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management.

Authors:  Marian Galovic; Carolina Ferreira-Atuesta; Laura Abraira; Nico Döhler; Lucia Sinka; Francesco Brigo; Carla Bentes; Johan Zelano; Matthias J Koepp
Journal:  Drugs Aging       Date:  2021-02-23       Impact factor: 3.923

5.  Seizures after Ischemic Stroke: A Matched Multicenter Study.

Authors:  Carolina Ferreira-Atuesta; Nico Döhler; Barbara Erdélyi-Canavese; Ansgar Felbecker; Philip Siebel; Natalie Scherrer; Giulio Bicciato; Juliane Schweizer; Lucia Sinka; Lukas L Imbach; Mira Katan; Laura Abraira; Estevo Santamarina; José Álvarez-Sabín; Michael Winklehner; Tim J von Oertzen; Judith N Wagner; Gian Luigi Gigli; Anna Serafini; Francesco Janes; Giovanni Merlino; Mariarosaria Valente; Giorgia Gregoraci; Julian Conrad; Stefan Evers; Piergiorgio Lochner; Frauke Roell; Francesco Brigo; Carla Bentes; Ana Rita Peralta; Teresa Pinho E Melo; Mark R Keezer; John S Duncan; Josemir W Sander; Barbara Tettenborn; Matthias J Koepp; Marian Galovic
Journal:  Ann Neurol       Date:  2021-09-30       Impact factor: 11.274

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.